Answers are grounded in this paper and cite their sources.
This narrative review reveals gerontological gaps in harm reduction for older drug users, suggesting improved service designs.
The population of people who use drugs (PWUD) in France has undergone a profound demographic shift, with adults aged 40 and over now representing over one-third of CAARUD users. Yet the structural architecture of French CAARUD services has not adapted accordingly. This narrative review identifies five dimensions of this gerontological blind spot: accelerating epidemiological greying of drug-using populations; age-specific vulnerabilities including polypharmacy, accelerated biological ageing, and cognitive impairment; structural mismatch between CAARUD design and older PWUD needs; international models demonstrating feasibility of gero-sensitive harm reduction; and identifiable policy levers within the French system. Five evidence-informed recommendations are proposed: systematic geriatric screening, interdisciplinary training, cross-sectoral partnerships, adapted physical environments, and legislative reform.
No takes yet. Share an insight, caveat, or question.
Alexandre DELFORGE (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: